Pharmacogenetics of Osteoporosis: A Pathway Analysis of the Genetic Influence on the Effects of Antiresorptive Drugs
Osteoporosis is a skeletal disorder defined by a decreased bone mineral density (BMD) and an increased susceptibility to fractures. Bisphosphonates and selective oestrogen receptor modulators (SERM) are among the most widely used drugs. They inhibit bone resorption by targeting the mevalonate and oe...
Saved in:
Main Authors: | Álvaro del Real (Author), Carmen Valero (Author), José M. Olmos (Author), Jose L. Hernández (Author), José A. Riancho (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024) -
Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
by: Chenggui Zhang, et al.
Published: (2021) -
EVALUATION OF THE EFFICIENCY OF ANTIRESORPTIVE THERAPY FOR OSTEOPOROSIS IN MULTIPAROUS WOMEN
by: I.G. MUKHAMEDOVA, et al.
Published: (2019) -
Implications in dental treatment during the use of antiresorptive drugs - a literature review
by: Aleksandra Dziewulska, et al.
Published: (2024) -
Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women
by: Amado José A, et al.
Published: (2008)